Low levels of IgM antibodies against phosphorylcholine are associated with fast carotid intima media thickness progression and cardiovascular risk in men

Objective: Low levels of IgM anti-phosphorylcholine (anti-PC) increase the risk of cardiovascular events (CVE). Here we investigate the association of low anti-PC with the progression of carotid intima media thickness (C-IMT) and incidence of CVE in a large cohort of individuals at high risk of CVE,...

Full description

Bibliographic Details
Published in:Atherosclerosis
Main Authors: Gigante, Bruna, Leander, Karin, Vikstrom, Max, Baldassarre, Damiano, Veglia, Fabrizio, Strawbridge, Rona J., McLeod, Olga, Gertow, Karl, Sennblad, Bengt, Shah, Sonia, Zabaneh, Delilah, Humphries, Steve E., Kauhanen, Jussi p, Rauramaa, Rainer, Smit, Andries J., Mannarino, Elmo, Giral, Philippe, Tremoli, Elena, Hamsten, Anders, Frostegard, Johan, De Faire, Ulf
Format: Article in Journal/Newspaper
Language:English
Published: 2014
Subjects:
Subclinical atherosclerosis
Risk factors
Cardiovascular events
Cardiovascular disease
Biomarker
Anti-PC
Carotid intima media thickness
Carotid intima media thickness progression
MYOCARDIAL-INFARCTION
EUROPEAN POPULATION
NATURAL ANTIBODIES
PROTECTIVE FACTORS
VASCULAR EVENTS
ATHEROSCLEROSIS
PREDICTOR
IMPROVE
TROMSO
WOMEN
Tromso
Online Access:https://hdl.handle.net/11370/c7b13430-ef42-45e7-a91e-ac324e4bfd26
https://research.rug.nl/en/publications/c7b13430-ef42-45e7-a91e-ac324e4bfd26
https://doi.org/10.1016/j.atherosclerosis.2014.07.030
Description
Summary:Objective: Low levels of IgM anti-phosphorylcholine (anti-PC) increase the risk of cardiovascular events (CVE). Here we investigate the association of low anti-PC with the progression of carotid intima media thickness (C-IMT) and incidence of CVE in a large cohort of individuals at high risk of CVE, the IMPROVE, a prospective multicenter European study. Methods: 3711 subjects (54-79 years) with at least three established cardiovascular risk factors were enrolled. Baseline serum levels of IgM anti-PC were measured by ELISA. Carotid ultrasound investigations were performed at baseline and after 15 and 30 months of follow-up. The risk of C-IMT progression and ischemic CVE associated with low anti-PC levels was tested by logistic regression and Cox regression analysis, respectively. Risk estimates were adjusted by center and conventional cardiovascular risk factors. Results: 3670 study participants were included in the present analysis and 213 CVE were recorded during a 3 year follow up. Anti-PC levels (U/ml) were classified into quartiles [Q1 40-64- 102]. In men, low levels of anti-PC (Q1) were associated with the highest (> 90th) percentile of the fastest C-IMT progression, i.e. the segment showing the fastest progression over 30 months in the whole carotid tree, with an OR of 1.41 (95%CI, 1.02-1.9) and with an increased risk of CVE with a multivariable adjusted HR of 1.85 (95%CI, 1.1-3.1). No significant associations were found in women. Conclusions: Low anti-PC levels increase the risk of CVE in men. This effect may be partly mediated by a fast C-IMT progression. (C) 2014 Elsevier Ireland Ltd. All rights reserved.

Similar Items